1. Home
  2. EMN vs CORT Comparison

EMN vs CORT Comparison

Compare EMN & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eastman Chemical Company

EMN

Eastman Chemical Company

HOLD

Current Price

$65.77

Market Cap

8.3B

Sector

Industrials

ML Signal

HOLD

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$117.29

Market Cap

9.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EMN
CORT
Founded
1920
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.3B
9.7B
IPO Year
1996
2001

Fundamental Metrics

Financial Performance
Metric
EMN
CORT
Price
$65.77
$117.29
Analyst Decision
Buy
Buy
Analyst Count
13
5
Target Price
$79.31
★ $96.50
AVG Volume (30 Days)
★ 958.2K
853.1K
Earning Date
04-30-2026
04-30-2026
Dividend Yield
★ 4.77%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 2.51
0.09
Revenue
★ $8,752,000,000.00
$761,407,000.00
Revenue This Year
$3.06
$26.08
Revenue Next Year
$3.47
$26.98
P/E Ratio
★ $26.48
$1,284.78
Revenue Growth
N/A
★ 12.79
52 Week Low
$56.11
$28.66
52 Week High
$83.47
$126.38

Technical Indicators

Market Signals
Indicator
EMN
CORT
Relative Strength Index (RSI) 38.83 55.49
Support Level $65.72 $108.33
Resistance Level $70.42 $124.30
Average True Range (ATR) 1.27 5.48
MACD 0.01 0.08
Stochastic Oscillator 28.72 73.81

Price Performance

Historical Comparison
EMN
CORT

About EMN Eastman Chemical Company

Established in 1920 to produce chemicals for Eastman Kodak, Eastman Chemical has grown into a global specialty chemical company with manufacturing sites around the world. The company generates the majority of its sales outside of the United States, with a strong presence in Asian markets. During the past several years, Eastman has sold noncore businesses, choosing to focus on higher-margin specialty product offerings.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

Share on Social Networks: